Publication Name	World Journal of Gastroenterology
Manuscript ID	6171
Country	Türkiye

Received	2013-10-07 15:22
Peer-Review Started	2013-10-08 09:12
To Make the First Decision	2013-12-16 17:59
Return for Revision	2013-12-17 11:10
Revised	2013-12-27 00:37
Second Decision	2014-01-20 18:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-20 19:13
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-03-23 19:48
Publish the Manuscript Online	2014-04-14 10:49

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Treatment options in patients with metastatic gastric cancer: Current status and future perspectives
Manuscript Source	Invited Manuscript
All Author List	Ahmet Bilici
Funding Agency and Grant Number
Corresponding Author	Ahmet Bilici, MD, Department of Medical Oncology, Medical Faculty, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214 Istanbul, Turkey. ahmetknower@yahoo.com
Key Words	Gastric cancer; Chemotherapy; Targeted therapy; Metastasis; Advanced-stage
Core Tip	Although palliative chemotherapy have been demonstrated to improve survival and quality of life, the prognosis of patients with metastatic gastric cancer remains poor and responses to first-line chemotherapy are partial and heterogeneous. In order to improve the results of currently available treatments, remarkable advancements in new targeted agents have recently been obtained. The addition of trastuzumab to cisplatin/fluoropyrimidine-based chemotherapy significantly improved survival in patients with human epidermal growth factor receptor 2-positive metastatic gastric cancer, which is now the new standard of care. Our manuscript will elucidate current systemic chemotherapy and promising targeted therapies for metastatic gastric cancer in the first- and second-line setting in the light of recent advances.
Publish Date	2014-04-14 10:49
Citation	Bilici A. Treatment options in patients with metastatic gastric cancer: Current status and future perspectives. World J Gastroenterol 2014; 20(14): 3905-3915
URL	http://www.wjgnet.com/1007-9327/full/v20/i14/3905.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i14.3905

Full Article (PDF)	WJG-20-3905.pdf
Full Article (Word)	WJG-20-3905.doc
Manuscript File	6171-Review.doc
Answering Reviewers	6171-Answering reviewers.pdf
Copyright License Agreement	6171-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6171-Language certificate.pdf
Peer-review Report	6171-Peer review(s).pdf
Scientific Editor Work List	6171-Scientific editor work list.doc